Clinical trial
Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary…
NCT00373841 · University of Pittsburgh, Other · Recruiting
Key facts
| NCT number | NCT00373841 |
|---|---|
| Title | Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF) |
| Official title | Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis |
| Acronym | GAP |
| Lead sponsor | University of Pittsburgh, Other |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Idiopathic Pulmonary Fibrosis |
| Enrollment | 500 |
| Start date | Oct 1, 2005 |
| Primary completion | Jul 1, 2030 |
| Completion | Jul 1, 2030 |
| First posted | Sep 8, 2006 |
| Last update posted | Oct 29, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: